Post-approval studies (Phase 4)Study completedNCT02184624
What this trial is testing
Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices
Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 569